Growth Metrics

Organon (OGN) Change in Accured Expenses (2020 - 2025)

Organon (OGN) has 6 years of Change in Accured Expenses data on record, last reported at -$156.0 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 113.7% year-over-year to -$156.0 million; the TTM value through Dec 2025 reached -$142.0 million, down 40.59%, while the annual FY2025 figure was -$142.0 million, 40.59% down from the prior year.
  • Change in Accured Expenses reached -$156.0 million in Q4 2025 per OGN's latest filing, down from $73.0 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $493.0 million in Q4 2021 and bottomed at -$234.0 million in Q2 2021.
  • Average Change in Accured Expenses over 5 years is $18.9 million, with a median of -$8.0 million recorded in 2022.
  • The widest YoY moves for Change in Accured Expenses: up 673.26% in 2021, down 1117.39% in 2021.
  • A 5-year view of Change in Accured Expenses shows it stood at $493.0 million in 2021, then crashed by 87.02% to $64.0 million in 2022, then rose by 6.25% to $68.0 million in 2023, then tumbled by 207.35% to -$73.0 million in 2024, then crashed by 113.7% to -$156.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$156.0 million in Q4 2025, $73.0 million in Q3 2025, and -$98.0 million in Q2 2025.